Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells
Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells have?
Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells has 156 citations in the OpenAlex counts ScholarIQ stores.
When was Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells published?
Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells has 2014 year in the ScholarIQ index.
What is the open-access status of Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells?
Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells has hybrid oa status in the ScholarIQ index.
What is the DOI of Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells?
The DOI for Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells is on the source record.
What is the PMID of Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells?
The PMID for Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells is on the source record.
What is the OpenAlex record for Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells?
The OpenAlex for Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells is on the source record.